CIK 0001613103 · Large accelerated filer
Medtronic plc
Sign in to watch- Ticker
- MDT
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Apr 24
- Entity type
- operating
- Phone
- 01135314381700
- Business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland, H91 4K49
- Former names
- Medtronic Ltd, Medtronic Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,889,203
- in 3 filings, $5.8M under 10b5-1 plans
Net −$5,889,203. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Marinaro Michael President | Grant or award | +6,547 | 113,353 | ||
| 2026-11-02 | Marinaro Michael President | Grant or award · Performance Share Units | +16,367 | 16,367 | ||
| 2026-11-02 | Marinaro Michael President | Grant or award · Stock Option (Right to Buy) | +42,994 | 42,994 | ||
| 2026-10-15 | Lofton Kevin E Director | Other disposition | −182 | 9,977 | ||
| 2026-10-15 | Marinaro Michael EVP, Pres MedSurg and Americas | Sale 10b5-1 | −10,420 | $96.00 | $1.0M | 105,916 |
| 2026-10-15 | Martha Geoffrey Chairman and CEO | Sale 10b5-1 | −50,000 | $95.00 | $4.8M | 277,866 |
| 2026-09-16 | KIIL HARRY SKIP EVP & President Cardiovascular | Sale | −1,483 | $93.65 | $139K | 42,186 |
| 2026-09-15 | Blomquist Denise L. Chief Accounting Officer | Gift | −600 | 16,398 | ||
| 2026-08-20 | Marinaro Michael EVP, Pres MedSurg and Americas | Shares withheld for taxes | −1,084 | $92.30 | $100K | 116,336 |
| 2026-08-03 | Thompson Kweli EVP & President, Neuroscience | Grant or award | +6,923 | 35,390 | ||
| 2026-08-03 | Thompson Kweli EVP & President, Neuroscience | Grant or award · Performance Share Units | +17,306 | 17,306 | ||
| 2026-08-03 | Thompson Kweli EVP & President, Neuroscience | Grant or award · Stock Option (Right to Buy) | +49,167 | 49,167 | ||
| 2026-08-03 | Blomquist Denise L. Chief Accounting Officer | Grant or award | +2,337 | 16,998 | ||
| 2026-08-03 | Blomquist Denise L. Chief Accounting Officer | Grant or award · Performance Share Units | +2,337 | 2,337 | ||
| 2026-08-03 | Blomquist Denise L. Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +1,366 | 1,366 | ||
| 2026-08-03 | Pieton Thierry EVP & Chief Financial Officer | Grant or award | +11,537 | 49,645 | ||
| 2026-08-03 | Pieton Thierry EVP & Chief Financial Officer | Grant or award · Performance Share Units | +28,842 | 28,842 | ||
| 2026-08-03 | Pieton Thierry EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +81,945 | 81,945 | ||
| 2026-08-03 | Walter Matthew R. SVP, Chief HR Officer | Grant or award | +5,769 | 39,928 | ||
| 2026-08-03 | Walter Matthew R. SVP, Chief HR Officer | Grant or award · Performance Share Units | +14,421 | 14,421 |
Page 1 of 12 · 239 trades